134 related articles for article (PubMed ID: 16583042)
1. Cost of schizophrenia: direct costs and use of resources in the State of São Paulo.
Leitão RJ; Ferraz MB; Chaves AC; Mari JJ
Rev Saude Publica; 2006 Apr; 40(2):304-9. PubMed ID: 16583042
[TBL] [Abstract][Full Text] [Related]
2. An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil.
Souza RJ; Mattedi AP; Rezende ML; Corrêa Mde P; Duarte EM
An Bras Dermatol; 2009 Jul; 84(3):237-43. PubMed ID: 19668936
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
4. Resource utilization and cost of rheumatic fever.
Terreri MT; Ferraz MB; Goldenberg J; Len C; Hilário MO
J Rheumatol; 2001 Jun; 28(6):1394-7. PubMed ID: 11409136
[TBL] [Abstract][Full Text] [Related]
5. Direct medical costs associated with schizophrenia relapses in health care services in the city of São Paulo.
Daltio CS; Mari JJ; Ferraz MB
Rev Saude Publica; 2011 Feb; 45(1):14-23. PubMed ID: 21085885
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis.
Marcellusi A; Fabiano G; Viti R; Francesa Morel PC; Nicolò G; Siracusano A; Mennini FS
BMJ Open; 2018 Feb; 8(2):e018359. PubMed ID: 29439067
[TBL] [Abstract][Full Text] [Related]
7. An Economic Evaluation of Coordinated Specialty Care (CSC) Services for First-Episode Psychosis in the U.S. Public Sector.
Murphy SM; Kucukgoncu S; Bao Y; Li F; Tek C; Breitborde NJK; Guloksuz S; Phutane VH; Ozkan B; Pollard JM; Cahill JD; Woods SW; Cole RA; Schoenbaum M; Srihari VH
J Ment Health Policy Econ; 2018 Sep; 21(3):123-130. PubMed ID: 30530872
[TBL] [Abstract][Full Text] [Related]
8. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
Ezenduka C; Ichoku H; Ochonma O
J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
[TBL] [Abstract][Full Text] [Related]
9. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
[TBL] [Abstract][Full Text] [Related]
10. The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil.
Borges NB; Ferraz MB; Chacra AR
Diabetol Metab Syndr; 2014; 6(1):122. PubMed ID: 25400703
[TBL] [Abstract][Full Text] [Related]
11. The Societal Costs of Schizophrenia in Switzerland.
Pletscher M; Mattli R; von Wyl A; Reich O; Wieser S
J Ment Health Policy Econ; 2015 Jun; 18(2):93-103. PubMed ID: 26231000
[TBL] [Abstract][Full Text] [Related]
12. The cost of schizophrenia treatment in Taiwan.
Lang HC; Su TP
Psychiatr Serv; 2004 Aug; 55(8):928-30. PubMed ID: 15292543
[TBL] [Abstract][Full Text] [Related]
13. The cost of schizophrenia: lessons from an international comparison.
Blomqvist AG; Léger PT; Hoch JS
J Ment Health Policy Econ; 2006 Dec; 9(4):177-83. PubMed ID: 17200594
[TBL] [Abstract][Full Text] [Related]
14. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
Marcus SC; Olfson M
Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
[TBL] [Abstract][Full Text] [Related]
15. An estimate of the cost of treating non-melanoma skin cancer in the state of São Paulo, Brazil.
Souza RJ; Mattedi AP; Corrêa MP; Rezende ML; Ferreira AC
An Bras Dermatol; 2011; 86(4):657-62. PubMed ID: 21987129
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia costs and treatment cost-effectiveness.
Knapp M
Acta Psychiatr Scand Suppl; 2000; (407):15-8. PubMed ID: 11261634
[TBL] [Abstract][Full Text] [Related]
17. Cost of a community mental health service: a retrospective study on a psychosocial care center for alcohol and drug users in São Paulo.
Becker P; Razzouk D
Sao Paulo Med J; 2018; 136(5):433-441. PubMed ID: 30570094
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of health care resource utilisation and selected costs of schizophrenia in France.
Sarlon E; Heider D; Millier A; Azorin JM; König HH; Hansen K; Angermeyer MC; Aballéa S; Toumi M
BMC Health Serv Res; 2012 Aug; 12():269-76. PubMed ID: 22909284
[TBL] [Abstract][Full Text] [Related]
19. Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.
Lefebvre P; Muser E; Joshi K; DerSarkissian M; Bhak RH; Duh MS; Shiner B; Young-Xu Y
Clin Ther; 2017 Jul; 39(7):1380-1395.e4. PubMed ID: 28641996
[TBL] [Abstract][Full Text] [Related]
20. [Analysis and comparative evaluations of the costs of supports and treatments of schizophrenia, affective psychosis, paranoia and neurosis].
Grassi A; Bruni R; Pileggi F; Chiappelli M; Boldrini M; Franceschi E; Scarafoni D
Epidemiol Psichiatr Soc; 2001; 10(2):115-24. PubMed ID: 11526793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
